Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression

Cancer Investigation

Volumn 26, Issue 2, 2008, Pages 185-192

  Lu, Lingeng ^a   Katsaros, Dionyssios ^b   Wiley, Andrew ^a   De La Longrais, Irene A Rigault ^b   Puopolo, Manuela ^b   Yu, Herbert ^a  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

IGF; Klotho; Ovarian cancer; Prognosis

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; KLOTHO PROTEIN; MESSENGER RNA; PACLITAXEL; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; ITALY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVARY CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYSTADENOCARCINOMA, SEROUS; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 38949155148     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701638343     Document Type: Article

References (34)

1. Kuro-o, M.; Matsumura, Y.; Aizawa, H.; Kawaguchi, H.; Suga, T.; Utsugi, T.; Ohyama, Y.; Kurabayashi, M.; Kaname, T.; Kume, E.; Iwasaki, H.; Iida, A.; Shiraki-Iida, T.; Nishikawa, S.; Nagai, R.; Nabeshima, Y.I. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390, 45-51.
2. Kurosu, H.; Yamamoto, M.; Clark, J.D.; Pastor, J.V.; Nandi, A.; Gurnani, P.; McGuinness, O.P.; Chikuda, H.; Yamaguchi, M.; Kawaguchi, H.; Shimomura, I.; Takayama, Y.; Herz, J.; Kahn, C.R.; Rosenblatt, K.P.; Kuro-o, M. Suppression of aging in mice by the hormone klotho. Science 2005, 309, 1829-1833.
3. Arking, D.E.; Krebsova, A.; Macek, M., Sr.; Macek, M., Jr.; Arking, A.; Mian, I.S.; Fried, L.; Hamosh, A.; Dey, S.; McIntosh, I.; Dietz, H.C. Association of human aging with a functional variant of klotho. Proc. Natl. Acad. Sci. USA 2002, 99, 856-861.
4. Arking, D.E.; Atzmon, G.; Arking, A.; Barzilai, N.; Dietz, H.C. Association between a functional variant of the klotho gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res. 2005, 96, 412-418.
5. Yamamoto, M.; Clark, J.D.; Pastor, J.V.; Gurnani, P.; Nandi, A.; Kurosu, H.; Miyoshi, M.; Ogawa, Y.; Castrillon, D.H.; Rosenblatt, K.P.; Kuro-o, M. Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 2005, 280, 38029-38034.
6. Matsumura, Y.; Aizawa, H.; Shiraki-Iida, T.; Nagai, R.; Kuroo, M.; Nabeshima, Y. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun. 1998, 242, 626-630.
7. Shiraki-Iida, T.; Aizawa, H.; Matsumura, Y.; Sekine, S.; Iida, A.; Anazawa, H.; Nagai, R.; Kuro-o, M.; Nabeshima, Y. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 1998, 424, 6-10.
8. Negri, A.L. The klotho gene: A gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism. J. Nephrol. 2005, 18, 654-658.
9. Chang, Q.; Hoefs, S.; van der Kemp, A.W.; Topala, C.N.; Bindels, R.J.; Hoenderop, J.G. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005, 310, 490-493.
10. Yu, H.; Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 2000, 92, 1472-1489.
11. Fukino, K.; Suzuki, T.; Saito, Y.; Shindo, T.; Amaki, T.; Kurabayashi, M.; Nagai, R. Regulation of angiogenesis by the aging suppressor gene klotho. Biochem. Biophys. Res. Commun. 2002, 293, 332-337.
12. Mitobe, M.; Yoshida, T.; Sugiura, H.; Shirota, S.; Tsuchiya, K.; Nihei, H. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron. Exp. Nephrol. 2005, 101, e67-74.
13. Beeghly, A.; Katsaros, D.; Chen, H.; Fracchioli, S.; Zhang, Y.; Massobrio, M.; Risch, H.; Jones, B.; Yu, H. Glutathione s-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol. Oncol. 2006, 100, 330-337.
14. Lu, L.; Katsaros, D.; Wiley, A.; Rigault de la Longrais, I.A.; Risch, H.A.; Puopolo, M.; Yu, H. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. Clin. Cancer Res. 2006, 12, 1208-1214.
15. Lu, L.; Katsaros, D.; Wiley, A.; Rigault de la Longrais, I.A.; Puopolo, M.; Schwartz, P.; Yu, H. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Gynecol. Oncol. 2006, 103, 990-995.
16. Arking, D.E.; Becker, D.M.; Yanek, L.R.; Fallin, D.; Judge, D.P.; Moy, T.F.; Becker, L.C.; Dietz, H.C. Klotho allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet. 2003, 72, 1154-1161.
17. Bartke, A. Long-lived klotho mice: New insights into the roles of IGF-1 and insulin in aging. Trends Endocrinol. Metab. 2006, 17, 33-35.
18. Wang, Y.A. Klotho, the long sought-after elixir and a novel tumor suppressor? Cancer Biol. Ther. 2006, 5, 20-21.
19. van Hinsbergh, V.W.; Collen, A.; Koolwijk, P. Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumors. Ann. Oncol. 1999, 10(Suppl 4), 60-63.
20. Brem, S.; Cotran, R.; Folkman, J. Tumor angiogenesis: A quantitative method for histologic grading. J. Natl. Cancer Inst. 1972, 48, 347-356.
21. Hollingsworth, H.C.; Kohn, E.C.; Steinberg, S.M.; Rothenberg, M.L.; Merino, M.J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol. 1995, 147, 33-41.
22. Alvarez, A.A.; Krigman, H.R.; Whitaker, R.S.; Dodge, R.K.; Rodriguez, G.C. The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Clin. Cancer Res. 1999, 5, 587-591.
23. Shimada, T.; Takeshita, Y.; Murohara, T.; Sasaki, K.; Egami, K.; Shintani, S.; Katsuda, Y.; Ikeda, H.; Nabeshima, Y.; Imaizumi, T. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004, 110, 1148-1155.
24. Mori, K.; Yahata, K.; Mukoyama, M.; Suganami, T.; Makino, H.; Nagae, T.; Masuzaki, H.; Ogawa, Y.; Sugawara, A.; Nabeshima, Y.; Nakao, K. Disruption of klotho gene causes an abnormal energy homeostasis in mice. Biochem. Biophys. Res. Commun. 2000, 278, 665-670.
25. Niedner, H.; Christen, R.; Lin, X.; Kondo, A.; Howell, S.B. Identification of genes that mediate sensitivity to cisplatin. Mol. Pharmacol. 2001, 60, 1153-1160.
26. Dumontet, C.; Sikic, B.I. Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death. J. Clin. Oncol. 1999, 17, 1061-1070.
27. Blanc, C.; Deveraux, Q.L.; Krajewski, S.; Janicke, R.U.; Porter, A.G.; Reed, J.C.; Jaggi, R.; Marti, A. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res. 2000, 60, 4386-4390.
28. Lu, K.H.; Lue, K.H.; Chou, M.C.; Chung, J.G. Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (u-2 os). J. Orthop. Res. 2005, 23, 988-994.
29. Lu, K.H.; Lue, K.H.; Liao, H.H.; Lin, K.L.; Chung, J.G. Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel. Clin. Chim. Acta. 2005, 357, 65-73.
30. Pan, J.; Xu, G.; Yeung, S.C. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. J. Clin. Endocrinol. Metab. 2001, 86, 4731-4740.
31. Agarwal, R.; Kaye, S.B. Ovarian cancer: Strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 2003, 3, 502-516.
32. Sugiura, H.; Yoshida, T.; Tsuchiya, K.; Mitobe, M.; Nishimura, S.; Shirota, S.; Akiba, T.; Nihei, H. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol. Dial. Transplant 2005, 20, 2636-2645.
33. Ikushima, M.; Rakugi, H.; Ishikawa, K.; Maekawa, Y.; Yamamoto, K.; Ohta, J.; Chihara, Y.; Kida, I.; Ogihara, T. Anti-apoptotic and anti-senescence effects of klotho on vascular endothelial cells. Biochem. Biophys. Res. Commun. 2006, 339, 827-832.
34. Utsugi, T.; Ohno, T.; Ohyama, Y.; Uchiyama, T.; Saito, Y.; Matsumura, Y.; Aizawa, H.; Itoh, H.; Kurabayashi, M.; Kawazu, S.; Tomono, S.; Oka, Y.; Suga, T.; Kuro-o, M.; Nabeshima, Y.; Nagai, R. Decreased insulin production and increased insulin sensitivity in the klothomutant mouse, a novel animal model for human aging. Metabolism 2000, 49, 1118-1123.